MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 208 filers reported holding MIRATI THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,383,000 | +20.2% | 7,818 | +9.7% | 0.00% | +33.3% |
Q2 2021 | $1,151,000 | +6.5% | 7,126 | +12.9% | 0.00% | -25.0% |
Q1 2021 | $1,081,000 | -15.9% | 6,310 | +7.8% | 0.00% | -20.0% |
Q4 2020 | $1,285,000 | +83.0% | 5,851 | +38.4% | 0.01% | +66.7% |
Q3 2020 | $702,000 | -6.1% | 4,227 | -35.5% | 0.00% | -40.0% |
Q2 2020 | $748,000 | +70.4% | 6,549 | +14.7% | 0.01% | +66.7% |
Q1 2020 | $439,000 | -24.3% | 5,710 | +26.9% | 0.00% | -25.0% |
Q4 2019 | $580,000 | +71.6% | 4,499 | +3.8% | 0.00% | +100.0% |
Q3 2019 | $338,000 | – | 4,336 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |